Organization · Venture Capital
Phase Two Ventures
Phase Two Ventures is a seed venture fund based in San Diego that invests in early-stage life science startups, focusing on R&D tools, platform technologies, and computational biology.
Overview
What Phase Two Ventures does
What Phase Two Ventures is
Phase Two Ventures is a seed venture fund based in San Diego that invests in early-stage life science startups, focusing on R&D tools, platform technologies, and computational biology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 7, 2026
Official channels
Find Phase Two Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Phase Two Ventures as a funder
Investment thesis
Phase Two Ventures invests in early-stage life science startups focusing on R&D tools, platform technologies, and computational biology to support advancements in diagnostics and therapeutics.
Focus narrative
The firm invests in early-stage life science tools, platform technologies, and computational biology. Its investment thesis highlights the potential of technologies that can drive the next generation of scientific discoveries, addressing critical challenges in research and development, diagnostics, and therapeutics.
Value beyond capital
Phase Two Ventures adds value to its portfolio companies by leveraging its expertise in life sciences, providing strategic guidance, and facilitating connections within the biotech ecosystem. The firm supports entrepreneurs in navigating the complexities of R&D and commercialization.
Terms and economics
- Typical check
- $100,000–$500,000
Focus and fit
- Stages
- Seed
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- Mesa Biotech and Sweetspot Diabetes
Portfolio context
Notable portfolio companies include: Navega Therapeutics, an AI-enabled zinc finger platform for gene therapies; Morphos Bioscience, a spatial biology platform; Potato, which develops autonomous agents for scientific methods; Exthymic, focused on accessible autologous cell therapies; Rybodyn, unlocking the dark proteome for drug discovery; and Mesa Biotech, a healthcare test company acquired by Thermo Fisher.
Common questions
What to know about Phase Two Ventures
Upseed classifies Phase Two Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.